BOSTON BIO SYSTEMS LTD. Fair Value
BOSTON BIO SYSTEMS LTD. (BOSTONBIO) average fair value is ₹6.58 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹5.39 (+22.14%), fair value range ₹3.85–₹8.57. For live price and a broader fundamental view, visit BOSTON BIO SYSTEMS LTD. share price today.
Fair Value Analysis Export
BOSTONBIO Fair Value vs Current Price — Valuation Summary
BOSTONBIO average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Explore BOSTONBIO fundamental worth to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
BOSTONBIO Fair Value Analysis — Data Sources & Coverage
BOSTON BIO SYSTEMS LTD. financial data sources, valuation methods applied and sector benchmarks used. Analyse BOSTONBIO FII DII holdings to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
BOSTONBIO vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
BOSTON BIO SYSTEMS LTD. P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| One Global Service Provi… | ONEGLOBAL | 17.46 | 10.73 | ₹1,126 |
| Fortis Healthcare | FORTIS | 73.41 | 7.64 | ₹71,815 |
| Gujarat Kidney and Super… | GKSL | 65.3 | 3.06 | ₹884 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.